Smoking cessation drug varenicline helps young adults quit vaping, clinical trial reveals

April 24, 2025 by medicalxpress.com

Smoking cessation drug varenicline helps young adults quit vaping, clinical trial reveals

Teens and young adults who used varenicline had over three times the success rate quitting vaping compared to those receiving counseling only, as per a Mass General Brigham study published in JAMA. Varenicline, proven effective for smoking cessation in adults, showed no participants returning to cigarettes. The study highlights the importance of medication in aiding young nicotine addicts, with varenicline offering a safe and effective solution for 16-to-25-year-olds looking to quit vaping. Research on alternative therapies and younger age groups is warranted. In addressing adolescent vaping addiction, varenicline emerged as a successful treatment avenue with no reported safety concerns.

medicalxpress

Categories:

TOP NEWS by REGION

newsmedical

July 27, 2023, 1:04 p.m. by news-medical.net

Tobacco dependence more likely in cigarette smokers, study reveals

Regions: Global

linkedin

July 28, 2023, 11:16 a.m. by linkedin.com

Forecasting Nicotine Pouches Market till 2023-2030

Regions: Global

regulatorwatch

July 30, 2023, 11:33 p.m. by regulatorwatch.com

Vital Warning | WHO Is Coming for Your Vapes at COP10 | RegWatch

Regions: Global

Colin

July 30, 2023, 8:51 p.m. by colinmendelsohn.com.au

Stop Smoking Start Vaping e-book now free

Regions: Global

insidesources

Aug. 8, 2023, 9:45 a.m. by insidesources.com

WHO Has Changed Course on Harm Reduction Before; It Must Do So Again

Regions: Global